Snake Bites 101

Author: Samantha Selesny, PGY-3
Associate Editor of Emergency Medicine Toxicology, EMRounds


Background:

  • Reported snake bites in the US: 5,000/year
    • Reporting is not mandatory
    • Only about 5 or 6 result in death
  • 25% of bites are from venomous snakes
  • Victims are typically male, ages 17-27
    • Alcohol is significantly associated with many snake bites
  • Venomous snakes are found everywhere in the US except Maine, Alaska and Hawaii.
  • Most bites occur in the southwest
  • Most bites occur between May and October (snakes hibernate in the winter)
  • Pearl: Snakes are called “venomous” not “poisonous”
    • Venomous – toxins are INJECTED into prey
    • Poisonous– toxin causes harm by INGESTING or TOUCHING it
  • Thousands of species of snakes worldwide

2 families of Venomous Snakes in the United States:

  • Viperidae (Crotalids, Pit Vipers)
Figure 1: Viperidae (Crotalids, Pit Vipers)
  • Elapidae (Coral Snakes)
Figure 2: Elapidae (Coral Snakes)

Key Features:

Viperidae (Crotalinae, Pit Vipers):

  • Account for 99% of venomous snakebites in the US
  • Named for heat sensing pit organs 
  • Pit vipers are different from true vipers, which are not endemic to the US
  • Crotalinae subfamily includes:
    • Rattlesnakes (see Figure 1 below)
    • Cottonmouths (water mocassins) (see Figure 2 below)
    • Copperheads (see Figure 3 below)
Figure 1: Crotalinae- Rattlesnake
Figure 2: Crotalinae- Cottonmouth
Figure 3: Crotalinae- Copperhead
  • Can identify a Pit Viper with 3 main features:
    1. Heat Sensing Pits
    2. Elliptical Pupils
    3. Triangular Shaped Head

Elipidae (Coral Snakes):

  • Only account for ~1% of venomous snake bites:
    • Not aggressive
    • Live mostly underground (no contact with humans)
    • Venom apparatus not as efficient (smaller mouths, need to maintain bite for longer to deliver enough venom)
  • Identifying a Coral Snake (vs non-venomous snake such as King snake)
    1. Snout color
      • Coral Snakes- black snouts (see Figure 4 below)
      • King Snakes- red snouts (see Figure 5 below)
    2. Ring Color
      • Coral Snakes- red and yellow rings adjacent
        • “Red touches yellow, kills a fellow”
      • King Snakes- red and black rings adjacent
        • “Red touches black, safe for Jack”
Figure 4: Coral Snake
Figure 5: King Snake

Presentation:

Viperidae (Pit Viper):

  • Venom is a complex solution of various proteins, peptides and enzymes
    • allows the snake to kill its prey quickly and begin the digestive process
  • Clinical Presentation:
    1. Cytotoxic: Severe pain and swelling at bite site
      • Ecchymosis,
      • Fluid filled or hemorrhagic bullae (Figure 6 below) or
      • Extensive tissue destruction
    2. Hemotoxic: Consumption of coagulation factors
      • Low Platelets
      • High PT, and
      • LOW fibrinogen
    3. Systemic toxicity (less common):
      • Oral Paresthesias
      • Metallic taste,
      • Fasciculations,
      • Hypotension, or
      • Anaphylaxis
Figure 6: Hemorrhagic bullae after sustaining a crotalid bite

Elapidae/Coral Snakes

  • Venom is an 𝝰-neurotoxin –> post-synaptic NMJ blockade –> systemic neurotoxicity
  • Causes serious systemic toxicity (rather than local findings found in crolatid bites)
  • Clinical Presentation
    • Neurologic abnormalities:
      • weakness,
      • numbness,
      • respiratory paralysis (immediate cause of death)
    • May require airway and respiratory management lasting several weeks
    • Typically presents ~1-7 hours after envenomation
    • Onset may be delayed up to 18 hrs, thus ALL patients with elapidae envenomation are admitted

Management

For ALL BITES:

  • ABCs always come first!
  • Identify snake and risk for venom exposure (pictures are very helpful)
  • Thorough H&P- including total exposure (other bites)
  • Draw out edge of edema/erythema (to track progression)
  • Pain control
  • Tetanus vaccination
  • Contact poison control early

Viperidae/Pit Vipers:

  • Labs on arrival and after 4-8 hours:
    • CBC (thrombocytopenia/anemia),
    • PT/fibrinogen (coagulopathy),
    • BMP (potassium/renal function),
    • CK (rhabdomyolysis)
  • If no symptoms within 6-8 hours, the patient can be considered medically cleared.
  • Do not use torniquets, local debridement or cautery
  • Note: Because children have smaller body mass, smaller limbs, and less subcutaneous tissue, they can potentially receive more venom per kg body weight and therefore have more clinical severity than adults.
  • CroFab (Crotalidae polyvalent immune fab):
    • Administer if:
      • severe local swelling/ecchymosis,
      • lab abnormalities (PT >15, fibrinogen <150, platelets <150), or
      • systemic symptoms (hypotension, airway edema, neurological symptoms)
    • All patients who receive crofab should be admitted for observation
    • Dosing CroFab antivenom (dosing units are by vials):
      • 1st dose: 4-6 vials,
        • Repeat dosing as needed
        • Maintenance dosing with 2-4 vials
      • Dosing is the same in pediatric patients
    • Most common reaction: anaphylaxis (ensure patient is closely monitored)
  • Disposition:
    • All patients who receive crofab should be admitted for observation
    • Most patients who require admission can go to the medical floors
    • ICU setting is reserved for those who require neuro checks or have severe systemic toxicity
    • Consults: consider surgical consult for signs of compartment syndrome despite antivenom treatment.
CroFab (for Viperiade/Pit Viper)

Elapidae/Coral Snakes

  • Administer Antivenin (specific for coral snakes) for systemic toxicity
  • Disposition: ALL patients are admitted for observation (potentially delayed onset)
Antivenin (for Coral Snake bites)

References:

  • Gold B.S., Dart R.C., Barish R.A. Bites of venomous snakes. N Engl J Med. 2002 Aug 1;347(5):347-56. doi: 10.1056/NEJMra013477. PMID: 12151473.
  • “Bites and Sings” Cydulka, R., Fitch, M., Joing, S., Wang, V., Cline, D., Ma, O. and Tintinalli, J., Tintinalli’s emergency medicine manual. 8th ed.
  • “Snakes and Other Reptiles” Riley, B.D., Pizon, A., Ruha, A.M., Goldfranks Toxicologic Emergencies, 9th ed., McGraw-Hill, 2002.
  • Spencer Greene et al. How Should Native Crotalid Envenomation Be Managed in the Emergency Department? J Emerg Med. 2021 Feb 20;S0736-4679(21)00029-9. doi: 10.1016/j.jemermed.2021.01.020. 
  • Jacobi Medical Center’s Snakebite Protocol

Leave a Reply

Your email address will not be published. Required fields are marked *